Senseonics (NYSEAMERICAN:SENS) Hits New 12-Month Low at $1.39

Senseonics Holdings, Inc. (NYSEAMERICAN:SENSGet Rating)’s share price hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $1.39 and last traded at $1.40, with a volume of 87820 shares trading hands. The stock had previously closed at $1.48.

SENS has been the subject of a number of recent research reports. Zacks Investment Research cut shares of Senseonics from a “hold” rating to a “strong sell” rating in a research report on Saturday, March 5th. Colliers Securities reaffirmed a “buy” rating on shares of Senseonics in a research note on Tuesday, March 22nd.

The firm has a market capitalization of $648.57 million, a price-to-earnings ratio of -1.69 and a beta of 0.61.

Senseonics (NYSEAMERICAN:SENSGet Rating) last released its quarterly earnings results on Tuesday, March 1st. The company reported $0.01 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.03) by $0.04. The firm had revenue of $4.01 million for the quarter, compared to the consensus estimate of $4.00 million. As a group, analysts expect that Senseonics Holdings, Inc. will post -0.16 earnings per share for the current fiscal year.

In related news, CFO Nick B. Tressler sold 72,873 shares of the company’s stock in a transaction that occurred on Friday, February 11th. The stock was sold at an average price of $2.46, for a total value of $179,267.58. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Edward Fiorentino sold 63,553 shares of the stock in a transaction that occurred on Friday, March 11th. The stock was sold at an average price of $1.65, for a total value of $104,862.45. The disclosure for this sale can be found here. Insiders sold 1,020,643 shares of company stock worth $2,459,304 over the last quarter. 5.60% of the stock is currently owned by company insiders.

Institutional investors have recently bought and sold shares of the business. BlackRock Inc. raised its position in shares of Senseonics by 16.5% during the fourth quarter. BlackRock Inc. now owns 31,075,724 shares of the company’s stock worth $82,972,000 after purchasing an additional 4,404,892 shares during the period. State Street Corp raised its position in shares of Senseonics by 7.4% during the fourth quarter. State Street Corp now owns 11,425,321 shares of the company’s stock worth $30,506,000 after purchasing an additional 791,351 shares during the period. Renaissance Technologies LLC raised its position in shares of Senseonics by 29.2% during the third quarter. Renaissance Technologies LLC now owns 7,423,000 shares of the company’s stock worth $25,164,000 after purchasing an additional 1,676,173 shares during the period. Geode Capital Management LLC raised its position in shares of Senseonics by 5.6% during the fourth quarter. Geode Capital Management LLC now owns 6,706,945 shares of the company’s stock worth $17,907,000 after purchasing an additional 353,248 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its position in shares of Senseonics by 1.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,937,355 shares of the company’s stock worth $7,843,000 after purchasing an additional 45,067 shares during the period. Hedge funds and other institutional investors own 26.81% of the company’s stock.

About Senseonics (NYSEAMERICAN:SENS)

Senseonics Holdings, Inc, a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months.

Featured Articles

Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.